TABLE 8.
Groupa | No. of sera | No. (%) of sera reactive with: |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DbpA |
p41i |
OspC |
VlsE |
BmpA |
P58 PBib | |||||||||||||
PBib | PBrb | PKob | B31b | PBi | PKo | 20047b | PBi | PKo | B31 | PBib | PKob | PKa2b | PBi | PKo | B31 | |||
EM | 15 | 0 (0.0) | 0 (0.0) | 1 (6.7) | 0 (0.0) | 0 (0.0) | 9 (60.0) | 9 (60.0) | 2 (13.3) | 11 (73.3) | 12 (80.0) | 8 (53.3) | 4 (26.7) | 3 (20.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
NB | 50 | 9 (18.0) | 3 (26.0) | 2 (4.0) | 0 (0.0) | 10 (20.0) | 19 (38.0) | 10 (20.0) | 3 (6.0) | 19 (38.0) | 26 (52.0) | 26 (52.0) | 7 (14.0) | 6 (12.0) | 5 (10.0) | 1 (2.0) | 3 (6.0) | 9 (18.0) |
ACA | 10 | 0 (0.0) | 0 (0.0) | 4 (40.0) | 0 (0.0) | 0 (0.0) | 4 (40.0) | 2 (20.0) | 0 (0.0) | 5 (50.0) | 2 (20.0) | 7 (70.0) | 1 (10.0) | 4 (40.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
AT | 10 | 3 (30.0) | 0 (0.0) | 2 (20.0) | 0 (0.0) | 1 (10.0) | 4 (40.0) | 3 (30.0) | 2 (20.0) | 6 (60.0) | 3 (30.0) | 5 (50.0) | 0 (0.0) | 4 (40.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Controls | 110 | 0 (0.0) | 1 (0.9) | 0 (0.0) | 0 (0.0) | 1 (0.9) | 1 (0.9) | 1 (0.9) | 0 (0.0) | 1 (0.9) | 2 (1.8) | 6 (5.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
For abbreviations, see Table 2, footnote a.
Additional antigen on the IgM line blot assay.